<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Enesi Pharma's ImplaVax® Solid-Dose and Needle-Free Vaccination Platform Wins Award at the World Vaccine Congress
Image Overlay - Enesi Pharma's ImplaVax® Solid-Dose and Needle-Free Vaccination Platform Wins Award at the World Vaccine Congress

Enesi Pharma's ImplaVax® Solid-Dose and Needle-Free Vaccination Platform Wins Award at the World Vaccine Congress

October 9, 2020

Enesi Pharma's ImplaVax® Solid-Dose and Needle-Free Vaccination Platform Wins Award at the World Vaccine Congress

Enesi Pharma, a biotechnology company developing next-generation vaccination products enabled by its ImplaVax® technologies, was awarded the 'Best New Vaccine Technology/Platform Award' at the World Vaccine Congress Washington Virtual annual event (28 September – 1 October 2020). Knowing the logitical challenges ahead in distributing COVID-19 vaccines, Yourway is paying close attention to such enabling technologies.

 Back to Index
Media

Upcoming Events

GCSG 2024 US Conference

April 21-24, 2024
Naples, Florida

Precision in Clinical Trials Summit (Boston)

May 6-7, 2024
Hilton Boston Park Plaza

Media

Articles

Regulatory barriers in cross-border European pharmaceutical transport

Open chat
Come chat with us!
Hello! How can I help you?